至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

KDM3A interacted with p53K372me1 and regulated p53 binding to PUMA in gastric cancer.

Biochem Biophys Res Commun. 2015; 
Li W, Lin S, Li W, Wang W, Li X, Xu D.
Products/Services Used Details Operation
Custom Vector Construction … scientiï¬ c, Lithuania) following the instruction of the kit. Real-time PCR was performed using SYBR-Green Premix PCR Master Mixneo-cGFP vector (GenScript Corporation). The speciï¬ c forward sequence for the shRNA … Get A Quote

摘要

Chemoresistance remains a major problem in the treatment of gastric cancer patients, leading to the serious limitation of efficacy of chemotherapeutic regime. However, the underlying mechanism remains largely unknown. In our present study, we for the first time found that knock down of KDM3A can promote apoptosis induced by chemoreagent Cisplatin and Paclitaxel through p53. Mechanistically, through promoting p53 binding to the promoter of PUMA. However, knock down of KDM3A as such doesn't affect p53 level. In addition, KDM3A can interact with p53K372me1 in protein-protein interaction fashion, leading to the inactivation of p53, may eventually leading to chemoresistance of gastric cancer.,Copyright © 2015 Elsev... More

关键词

Chemoresistance; Gastric cancer; KDM3A; p53; p53K372me1